SCHEMBL2637017

SCHEMBL2637017

CCCCCCC(C/C=C/CCCCCCCC=O)O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.40
TRPV1 Q8NER1 3/20 0.40
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
SOAT2 O75908 1/20 0.35
SOAT1 P35610 1/20 0.35
TSHR P16473 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
EPHX2 P34913 1/20 0.34
CES1 P23141 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14935617 1.00 FAAH (0.40) FAAHTRPV1FFAR1FFAR4SOAT2
SCHEMBL2637018 1.00 FAAH (0.40) FAAHTRPV1FFAR1FFAR4SOAT2
SCHEMBL14935616 1.00 FAAH (0.40) FAAHTRPV1FFAR1FFAR4SOAT2
SCHEMBL2636981 0.94 FFAR1 (0.36) FAAHTRPV1FFAR1FFAR4SOAT2
SCHEMBL2636982 0.94 FFAR1 (0.36) FAAHTRPV1FFAR1FFAR4SOAT2
SCHEMBL16705754 0.91 TSHR (0.39) FAAHTRPV1TSHRCYP1A2CYP3A4
SCHEMBL2641777 0.89 ALDH1A1 (0.41) TRPV1FFAR1FFAR4SOAT2SOAT1
SCHEMBL2641780 0.89 ALDH1A1 (0.41) TRPV1FFAR1FFAR4SOAT2SOAT1
SCHEMBL14935363 0.89 ALDH1A1 (0.41) TRPV1FFAR1FFAR4SOAT2SOAT1
SCHEMBL2641862 0.89 ALDH1A1 (0.41) TRPV1FFAR1FFAR4SOAT2SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569276-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF Protiva Biotherapeutics Inc. (CA) 2013-03-20 EP disclosed
WO-2011141703-A1 COMPOSITIONS AND METHODS FOR SILENCING APOLIPOPROTEIN B PROTIVA BIOTHERAPEUTICS INC. (CA) 2011-11-17 WO disclosed
WO-2011141705-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF PROTIVA BIOTHERAPEUTICS, INC. (CA) 2011-11-17 WO disclosed